Jeff Garro
Stock Analyst at Stephens & Co.
(1.21)
# 3,736
Out of 5,090 analysts
56
Total ratings
36.84%
Success rate
-10.69%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $23.92 | +33.78% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $14.88 | +14.25% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $4.05 | +122.22% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $20.53 | +55.87% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $20.14 | -0.70% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $23.84 | +17.45% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $242.07 | +15.67% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.68 | +86.57% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $9.48 | +79.32% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.62 | +90.84% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $50.37 | +9.19% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $222.68 | +12.27% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.95 | -14.79% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.66 | +265.54% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $19.43 | +2.93% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.16 | -24.42% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.43 | +109.79% | 3 | May 6, 2022 |
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.92
Upside: +33.78%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $14.88
Upside: +14.25%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $4.05
Upside: +122.22%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $20.53
Upside: +55.87%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $20.14
Upside: -0.70%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $23.84
Upside: +17.45%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $242.07
Upside: +15.67%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.68
Upside: +86.57%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $9.48
Upside: +79.32%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.62
Upside: +90.84%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $50.37
Upside: +9.19%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $222.68
Upside: +12.27%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.95
Upside: -14.79%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.66
Upside: +265.54%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $19.43
Upside: +2.93%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.16
Upside: -24.42%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.43
Upside: +109.79%